Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-18

Clinical Trial Update: Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

View source ↗

Summary

A completed genetic analysis study investigating chronic central serous chorioretinopathy that masquerades as neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sequenom, Inc. | Conditions: Age Related Macular Degeneration, Choroidal Neovascularization | Status: COMPLETED